NDC 71872-7232-01 - SOLU-MEDROL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71872-7232
- Requested NDC
- 71872-7232-01
- Package NDCs from labels
- 71872-7232-1, 71872-7232-01
- Manufacturer
- Medical Purchasing Solutions, LLC
- Effective date
- 2023-05-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SOLU-MEDROL - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7232-1 | SOLU-MEDROL | 2 mL in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 2 | 2 | |
| 71872-7232-1 | SOLU-MEDROL | 1 in 1 BAG | INJECTION, POWDER, FOR SOLUTION | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71872-7232 | SOLU-MEDROL (METHYLPREDNISOLONE SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION [MEDICAL PURCHASING SOLUTIONS, LLC] | 2 | Current NDC, Legacy NDC, 2 package rows | 20230509_b635e21b-d68d-f60b-e053-2995a90a0f46.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sunmark Saline Single Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Strategic Sourcing Services LLC | 06720229-7d58-499e-b7de-cb4bda5ae416 | 2026-01-08 | Warnings | GR686LBA74 |
| HealthMart Saline Single Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Strategic Sourcing Services LLC | 689228de-1f3e-4205-853d-6004d6248857 | 2026-01-08 | Warnings | GR686LBA74 |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 7e38b09c-da41-4ee3-8f99-812d3276d551 | 2025-12-19 | Warnings, Adverse reactions | NDA011856 207191 311659 LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | ProPharma Distribution | 42df21df-9284-4505-e063-6294a90a7024 | 2025-12-18 | Warnings, Adverse reactions | NDA011856 207191 311659 LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE | Tianjin Kingyork Pharmaceuticals Co., Ltd | 77a8d96c-37df-4f3a-9757-b2d4131ff82b | 2025-12-18 | Warnings, Adverse reactions | 1357886 1743704 314099 311659 LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE | Amneal Pharmaceuticals LLC | e86fbda8-00e4-4d54-841a-59dea6c15e70 | 2025-12-15 | Warnings, Adverse reactions | 1743704 311659 LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | cd99be87-c8d9-48d6-a8e5-e081052e3f19 | 2025-12-02 | Warnings, Adverse reactions | NDA011856 0009-0047 1357886 1743720 1743707 1743704 1357888 207191 1743722 207193 314099 1743729 1743726 311659 c157d266-8633-4c2e-ae1f-0207e4f19b35 cd99be87-c8d9-48d6-a8e5-e081052e3f19 LEC9GKY20K |
| Uro-MP | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE | Method Pharmaceuticals, LLC | 1e1b0dee-1a3b-4846-a212-c9febb3fc17d | 2025-10-29 | Warnings, Adverse reactions | KH7I04HPUU |
| Leader Ready to Use Saline Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Cardinal Health | 1b4f9c28-0547-4922-aa15-990c6fd9dc9f | 2025-09-29 | Warnings | GR686LBA74 |
| Saline Laxative | SALINE LAXATIVE | Major Pharmaceuticals | b3758ffe-1bac-4df6-9714-5e33e9d28d90 | 2025-09-16 | Warnings | GR686LBA74 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | ProPharma Distribution | 38698075-ac58-b5a4-e063-6294a90a7848 | 2025-07-18 | Warnings, Adverse reactions | NDA011856 1743707 1743704 LEC9GKY20K |
| Rexall Ready to use 4pk LAXATIVE | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Dolgencorp, LLC | 78509915-0ef1-4238-99a5-78a49a68f98f | 2025-07-07 | Warnings | GR686LBA74 |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | GR686LBA74 |
| Saline Laxative | SODIUM PHOSPHATE | Walgreen Company | fb260df0-7bda-4299-84a5-44c8f9447798 | 2025-06-18 | Warnings | GR686LBA74 |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | GR686LBA74 |
| Saline Enema | SODIUM PHOSPHATE MONOBASIC, SODIUM PHOSPHATE DIBASIC | Dynarex Corporation | 7c7b68af-4ef2-4f84-9279-9f7a91c8d9c5 | 2025-05-14 | Warnings | GR686LBA74 |
| SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT | SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT | HF Acquisition Co LLC, DBA HealthFirst | 99b3c99a-79d5-6c54-e053-2a95a90a28bc | 2025-01-08 | Warnings, Adverse reactions | NDA011856 1743720 LEC9GKY20K |
| Foster and Thrive Ready to Use Saline Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | McKesson | e5fdfcfd-5340-4929-9f68-2696110cca8e | 2025-01-07 | Warnings | GR686LBA74 |
| NativeRemedies Acid Free-Flux | CALC PHOS 9X, CARBO VEG 6C, MAG CARB 6C, NAT PHOS 9X, SILICEA 9X | Silver Star Brands | d5012b1f-861e-40b8-e053-2a95a90a4fe2 | 2025-01-01 | Warnings | GR686LBA74 |
| Belly Calm | ARG NIT, ASAFOETIDA, CARBO VEG, CHAMOMILLA, LYCOPODIUM, MAG PHOS, NAT PHOS, NUX MOSCH, ZINGIBER. | Silver Star Brands | e661bbd8-6a1d-1019-e053-2995a90ae888 | 2025-01-01 | Warnings | GR686LBA74 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.